![Jiajie Diao](https://www.uc.edu/news/articles/2023/07/n21182582/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1690556226979.jpg)
UC cancer researcher pioneers method of detecting early-stage cancers
New assay is cheaper, faster, less invasive and more accurate than current methods
No one wants to hear a diagnosis of cancer, but if anything is worse, it would be a diagnosis that comes too late.
Jiajie Diao, associate professor in the University of Cincinnati College of Medicine, has invented a method for detecting early-stage cancers that could help his colleagues at UC and worldwide save many lives.
The route to this breakthrough runs through a coffee shop. It began, of course, with Diao’s natural curiosity and interest in science, his degree work at the University of Illinois and a postdoc at Stanford University. But Diao remembers taking a coffee break during the postdoc and “chatting with the person next to me, and it turns out he was doing biomarker labeling. I was working on imaging, and I thought, ‘Let’s do something together.’”
The science that grew from that collaboration led first to an early pancreatic cancer detection procedure that received Food and Drug Administration breakthrough designation, then continued to grow at UC’s Vontz Center for Molecular Studies, where Diao has perfected a new assay for diagnosing cancer and cancer progression that is cheaper than current procedures, faster, less invasive and, most importantly, more accurate.
“Ultra-sensitive detection methods are required for diagnosing early-stage cancers,” Diao said.
He describes his method, called single molecule epigenetic localization, as “a little like fishing.” It uses a long strand of DNA to gather cell-free DNAs that are released by cancer cells and float free in a sample of blood (or urine, for kidney and bladder cancer), looking for DNA epigenetic modifications.
“These play important functions in a broad range of physiological and pathological processes,” Diao explained. Their dysregulation can lead to a variety of human diseases.
Researchers then take a look at the epigenetic modifications of this dysregulated DNA — one type, called 5-hmC, has been recently linked to several types of cancer — by placing it on a microscope slide, then fluorescing and imaging it to learn not just how many cell-free DNA modifications exist, but where.
This is a dramatic advance, Diao said. “Current methods of epigenetic imaging are still blind to the specific genomic location of these modifications.”
His invention, which he has successfully tested, “will provide additional insight to the diagnosing practitioner about where dysregulation exists, if cancer is the cause and whether that cancer has progressed.” The new method offers remarkably high accuracy even in the earliest stages of cancer, Stages 1 and 2.
“That information is critical for early treatment,” Diao said, “especially in the case of lung, pancreatic and other aggressive cancers.”
Diao and his co-inventor, Chun-Xiao Song, associate professor at the University of Oxford, are collaborating with UC’s Technology Transfer team. The duo have started the patent process and are now seeking partners to commercialize their technology. Those interested in further developing or licensing their assay should contact the tech transfer team.
Featured image at top: Jiajie Diao and his collaborator are working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Photo/Colleen Kelley/UC Marketing + Brand
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
SELF: 6 things you should know about exercise and the COVID-19 vaccines
May 4, 2021
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases, was one of the sources cited in an article published by SELF on six things to know about exercise and COVID-19 vaccines.
Fox19: World Voice Day with UC Health
April 15, 2021
Rebecca Howell, MD, of the Department of Otolaryngology-Head and Neck Surgery in the UC College of Medicine, was interviewed by WXIX-TV, Fox19 about World Voice Day coming up on Friday, April 16.
Cincinnati.com: It's spring. You're vaccinated. We asked docs what they feel is safe, what they'd avoid
April 12, 2021
Jennifer Forrester, MD, of the UC College of Medicine Division of Infectious Diseases was one of the expert sources cited in an article on Cincinnati.com on how safe or unsafe doctors feel certain activities are as we get into spring and more and more people are vaccinated against COVID-19.
The Body: How one Black woman wrestles with vaccine hesitancy
April 20, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources cited in an article published in The Body about the author's concern about getting the COVID-19 vaccine. Fichtenbaum stressed the safety and efficacy of the vaccines and said they would not interere with treatments for cancer and HIV/AIDS.
Medscape: New study confirms kidney dialysis worsens pregnancy outcomes
April 30, 2021
Silvi Shah, MD, of the Division of Nephrology, Kidney CARE Program, at the UC College of Medicine, was cited as a source in a Medscape story on new research showing that kidney dialysis worsens outcome for pregnant women.
WCPO-TV: Experts: Reopening states still far from herd immunity
June 8, 2021
Masks are coming off in Ohio, Kentucky and Indiana, thanks to widespread availability of the COVID-19 vaccine and politicians’ increasing willingness to let unvaccinated people roll the dice on their own health. WCPO-TV interviewed Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases who said any amount of vaccination is helpful in preventing the novel coronavirus from spreading, but unvaccinated people are still in danger as social gatherings and indoor events resume.
Cincinnati.com: COVID-19: When will Ohio gain protective herd immunity from vaccines? Doctors can't be sure
April 6, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of three experts Cincinnati.com turned to on a story about when Ohio will gain herd immunity against COVID-19.
Faculty Awards 2021: Kenneth Sherman
April 8, 2021
Kenneth E. Sherman, MD, PhD, is Gould Professor of Medicine and Director of the UC Division of Digestive Diseases in the Department of Internal Medicine. He is this year recipient of the University of Cincinnati Distinguished Research Professor Award.
Good Housekeeping: When will kids get COVID-19 vaccines? Experts share a timeline to keep in mind
April 9, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases in the UC College of Medicine was featured in an article in Good Housekeeping on when we can expect to see COVID-19 vaccines ready to be given to children.
Local 12: What researchers say we should know about heart inflammation and COVID-19 vaccine
May 25, 2021
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases was interviewed by two local TV stations for a story they did on myocarditis and COVID-19 vaccines. An advisory committee to the CDC is looking into reports that some teenagers and young adults who have received the COVID-19 vaccine have experienced heart inflammation. They’re reviewing these cases to see if there’s a possible connection.